Is 400mg per Week of Testosterone Sustainable for Life? Doctor’s Analysis

Member Access Required

Already a member? Sign In

Timeline

00:00

He explains why 400 milligrams weekly became common in blast and cruise culture over time. He frames sustainability as net health rather than only short term strength and confidence.

02:58

He discusses historical cruising norms and contrasts them with modern higher dose expectations. He explains why many men feel great yet still need to think about long term consequences.

05:58

He introduces cardiovascular concerns and emphasizes monitoring blood pressure and hypertension trends. He explains that problems can develop silently even when energy and mood feel improved.

09:00

He discusses polycythemia and clot risk and mentions DVT as a serious complication to avoid. He warns that pulmonary embolism can be catastrophic when thick blood and risk factors combine.

11:59

He expands to stroke and heart attack risk and explains how cumulative exposure changes probability. He emphasizes that risk rises when multiple markers worsen at the same time.

15:01

He discusses mental health and mentions depression and anxiety as outcomes some men report. He also describes libido changes and sexual effects that can appear with long term dosing.

17:59

He discusses prostate exposure and mentions BPH concerns with chronic androgen stimulation. He encourages monitoring and minimizing exposure while maintaining symptom relief and stability.

21:00

He discusses management tools like finasteride, HCG, and clomid in the broader planning conversation. He emphasizes that individualized oversight matters when making long term hormone decisions.

23:00

He closes by recommending the lowest effective dose and continued learning through community discussion. He invites men to share their experiences so others can make safer long term choices.

Video Summary

The speaker says a weekly dose of four hundred milligrams has become a common blast and cruise pattern. He compares it to older eras where lower cruising doses like Sustanon were more typical. He explains that many men report feeling great on this dose and ask if it can last forever. He frames the answer around net health, meaning long term outcomes beyond short term performance. He states that higher androgen exposure can amplify risks across multiple organ systems. He emphasizes that the question is not only about feeling good today but also about future damage. He sets up a harm reduction discussion focused on sustainability, monitoring, and dose minimization.

He warns about cardiovascular strain and mentions blood pressure and hypertension as important markers. He discusses blood changes and references polycythemia as a complication that can raise clot risks. He mentions DVT and pulmonary embolism as serious events that can occur in high risk settings. He adds that stroke and heart attack risk can rise when multiple risk factors accumulate over years. He also discusses mental health and mentions depression and anxiety as possible longer term issues. He warns that high doses can affect libido and sexual function in ways people do not expect. He argues that sustainable therapy requires tracking objective data rather than chasing a feeling.

He discusses the prostate and mentions BPH style symptoms and androgen exposure concerns over time. He references protective or management strategies like monitoring, and he mentions finasteride in context. He also mentions HCG and clomid in the conversation about long term hormone management choices. He suggests that cholesterol management sometimes includes statins when risk profiles justify treatment. He encourages viewers to use available tools and resources and to work toward the lowest effective dose. He closes by asking men to share experiences so others understand both good and bad outcomes. Overall, he frames the safest long term approach as minimizing exposure while maintaining quality of life.

Drug Callouts

Testosterone

Testosterone is an androgen hormone prescribed for replacement therapy when levels are clinically low. He discusses weekly testosterone dosing and asks whether 400 milligrams can be sustainable for life.

Sustanon

Sustanon is an injectable blend of testosterone esters used medically for testosterone replacement therapy. He references Sustanon as an older example of lower cruising doses used in past decades.

HCG

HCG is a hormone medication used to stimulate testicular testosterone production and preserve fertility. He mentions HCG as part of longer term hormone management decisions in some testosterone users.

Clomid

Clomid is clomiphene citrate, a selective estrogen receptor modulator used to stimulate gonadotropin release. He mentions clomid as a management option discussed in the broader context of hormone therapy planning.

Finasteride

Finasteride is a 5 alpha reductase inhibitor used to reduce DHT and slow androgen related hair loss. He mentions finasteride while discussing long term androgen exposure management considerations.

Statins

Statins are cholesterol lowering medications that reduce LDL and can lower cardiovascular event risk. He mentions statins when discussing cardiovascular risk management alongside long term testosterone use.

Condition Callouts

Hypertension

Hypertension is persistently elevated blood pressure that increases heart, kidney, and vessel damage risk. He emphasizes blood pressure monitoring because hypertension can worsen with long term high dose use.

Polycythemia

Polycythemia is an abnormal increase in red blood cell mass that can thicken blood and raise clotting risk. He describes polycythemia as a monitoring priority when testosterone doses stay high for years.

Deep vein thrombosis

Deep vein thrombosis is a blood clot in a deep vein that can cause swelling and life threatening embolism. He mentions DVT as a severe complication linked to thicker blood and other accumulated risk factors.

Pulmonary embolism

Pulmonary embolism is blockage of a pulmonary artery, often from a migrating deep vein clot. He mentions pulmonary embolism as a catastrophic outcome that can occur if clot risk is ignored.

Stroke

Stroke is a sudden disruption of brain blood flow that can cause permanent neurologic injury. He mentions stroke when warning about cardiovascular consequences that may appear after years of exposure.

Heart attack

Heart attack is myocardial injury caused by reduced coronary blood flow and oxygen delivery to heart tissue. He mentions heart attack risk in the context of cumulative blood pressure and vascular strain.

Benign prostatic hyperplasia

Benign prostatic hyperplasia is noncancerous prostate enlargement that can cause urinary symptoms in older men. He mentions BPH concerns when discussing chronic androgen exposure and prostate monitoring needs.

Depression

Depression is a mood disorder marked by persistent low mood and reduced interest in daily activities. He mentions depression as a possible longer term mental health issue for some testosterone users.

Anxiety

Anxiety is a condition involving excessive worry, heightened arousal, and impaired daily functioning over time. He mentions anxiety as another mental health concern that can appear with long term hormone management.

Key Takeaways

He says 400 milligrams weekly has become a common blast and cruise testosterone pattern.
He frames sustainability around net health rather than only short term strength and energy.
He warns about blood pressure, polycythemia, and clot risks like DVT and pulmonary embolism.
He mentions stroke, heart attack, mental health issues, and prostate concerns with chronic exposure.
He recommends moving toward the lowest effective dose with monitoring and shared learning.